{
    "clinical_study": {
        "@rank": "158166", 
        "arm_group": [
            {
                "arm_group_label": "Atorvastatin", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will take atorvastatin 20mg per night, totally 2 years."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Patients will take placebo once per night for 2 years. The appearance and dosage of placebo will be the same as atorvastatin."
            }
        ], 
        "brief_summary": {
            "textblock": "Patients with head and neck cancer who underwent irradiation have a higher risk of\n      developing severe carotid stenosis, and eventually develop to transient ischemic attack or\n      stroke. However, it's still not clear whether early intervene in vascular risk factors is\n      benefit for patients after radiotherapy.\n\n      Our study aimed to evaluate the feasibility and safety of atorvastatin for preventing NPC\n      patients after radiotherapy from severe carotid stenosis. In a randomized, double-blind,\n      placebo-controlled trial, about 324 nasopharyngeal carcinoma (NPC) patients will be enrolled\n      from six centers in Guangdong Province and randomized 1:1 to atorvastatin group or placebo\n      group."
        }, 
        "brief_title": "Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis", 
        "completion_date": {
            "#text": "January 2024", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Nasopharyngeal Carcinoma", 
            "Radiation Therapy Complication"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carotid Stenosis", 
                "Constriction, Pathologic", 
                "Nasopharyngeal Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "It is a randomized, double-blind, placebo-controlled trial, about 324 nasopharyngeal\n      carcinoma (NPC) patients will be enrolled from six centers in Guangdong Province and\n      randomized 1:1 to atorvastatin group (20mg per night, totally 2 years) or placebo group. All\n      Patients will be followed up for 2 years. Ultrasound and Transcranial Color Doppler (TCD)\n      will be used to evaluate the changes of intima-media thickness (IMT) and occurrence of\n      plaque formation of carotid arteries. Safety will be monitored every 6 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients must have received radiation therapy for histologically confirmed\n             nasopharyngeal carcinoma.\n\n          -  Prior irradiation <3 years prior to study entry.\n\n          -  Male or fertile women who are willing to take contraception during the trial.\n\n          -  Age 40-65 years old.\n\n          -  Carotid stenosis < 50%.\n\n          -  LDL-C between 100mg/dL\uff082.5mmol/L\uff09and 190mg/dL\uff084.9mmol/L\uff09.\n\n          -  Ability to understand and the willingness to sign a written informed consent\n             document.\n\n        Exclusion Criteria:\n\n          -  History of bleeding related to tumor or radiotherapy during or after radiation.\n\n          -  Evidence of tumor invasion to major vessels(for example the carotid artery).\n\n          -  Severe complications, such as history of stroke, myocardial infarction, liver\n             diseases, thyroid dysfunction, inadequately controlled hypertension and epilepsy.\n\n          -  Familial hypercholesterolemia.\n\n          -  Taking lipid-lowing drugs.\n\n          -  Aspartate aminotransferase(AST) or alanine aminotransferase(ALT) >upper limits of\n             normal (ULN), creatinine >ULN.\n\n          -  Allergic history of atorvastatin."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "324", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02022293", 
            "org_study_id": "2013018", 
            "secondary_id": "SYSN003"
        }, 
        "intervention": [
            {
                "arm_group_label": "Atorvastatin", 
                "description": "Patients in this group will take 20mg per night.", 
                "intervention_name": "Atorvastatin", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Atorvastatin Calcium Tablets", 
                    "Lipitor"
                ]
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Atorvastatin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Nasopharyngeal Carcinoma", 
            "Radiotherapy", 
            "Carotid Stenosis", 
            "Atorvastatin"
        ], 
        "lastchanged_date": "February 7, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Weimin Xiao, Ph.D"
                }, 
                "facility": {
                    "address": {
                        "city": "Dongguan", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "523059"
                    }, 
                    "name": "Dongguan People's Hospital"
                }, 
                "investigator": {
                    "last_name": "Weimin Xiao, Ph.D", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "2353352460@qq.com", 
                    "last_name": "Ying Peng, Ph.D", 
                    "phone": "+8613380051581"
                }, 
                "contact_backup": {
                    "email": "yameitang@hotmail.com", 
                    "last_name": "Yamei Tang, Ph.D", 
                    "phone": "+8613556001992"
                }, 
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "510120"
                    }, 
                    "name": "Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University"
                }, 
                "investigator": {
                    "last_name": "Ying Peng, Ph.D", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "sunying2@mail.sysu.edu.cn", 
                    "last_name": "Ying Sun, Ph.D", 
                    "phone": "+8613688856258"
                }, 
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "510060"
                    }, 
                    "name": "Sun Yat-sen University Cancer Center"
                }, 
                "investigator": {
                    "last_name": "Ying Sun, Ph.D", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "super-shen@126.com", 
                    "last_name": "Qingyu Shen, Ph.D", 
                    "phone": "+8613609710406"
                }, 
                "facility": {
                    "address": {
                        "city": "Zengcheng", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "511300"
                    }, 
                    "name": "Zengcheng People's Hospital"
                }, 
                "investigator": {
                    "last_name": "Qingyu Shen, Ph.D", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "zhaobime@163.net", 
                    "last_name": "Bin Zhao, Ph.D"
                }, 
                "facility": {
                    "address": {
                        "city": "Zhanjiang", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "524001"
                    }, 
                    "name": "The Affiliated Hospital of Guangdong Medical College"
                }, 
                "investigator": {
                    "last_name": "Bin Zhao, Ph.D", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mdqc6639@126.com", 
                    "last_name": "Chao Qin, Ph.D"
                }, 
                "facility": {
                    "address": {
                        "city": "Nanning", 
                        "country": "China", 
                        "state": "Guangxi", 
                        "zip": "530021"
                    }, 
                    "name": "The First Affiliated Hospital of Guangxi Medical University"
                }, 
                "investigator": {
                    "last_name": "Chao Qin, Ph.D", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis: A Multicenter, Double-blind, Placebo-Controlled, Randomized Trial", 
        "overall_contact": {
            "email": "2353352460@qq.com", 
            "last_name": "Ying Peng, Ph.D", 
            "phone": "+8613380051581"
        }, 
        "overall_contact_backup": {
            "email": "yameitang@hotmail.com", 
            "last_name": "Yamei Tang, Ph.D", 
            "phone": "+8613556001992"
        }, 
        "overall_official": {
            "affiliation": "Sun Yat-sen Memorial Hospital, Sun Yat-sen University", 
            "last_name": "Ying Peng, Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2023", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients will take Ultrasound and Transcranial Color Doppler every 6 months to measure the thickness of intima-media thickness (IMT) and occurrence of plaque formation of carotid arteries. We will compare the maximal IMT of bilateral carotid arteries at 2 years from baseline.", 
            "measure": "Change from baseline in maximal of IMT of bilateral carotid arteries", 
            "safety_issue": "No", 
            "time_frame": "At baseline and 2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02022293"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", 
            "investigator_full_name": "Yamei Tang", 
            "investigator_title": "Professer", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Patients will be followed up for 2 years. We defined sever carotid stenosis as stenosis>50% by using ultrasound and TCD.", 
                "measure": "Incidence of sever carotid stenosis", 
                "safety_issue": "No", 
                "time_frame": "At 2 years"
            }, 
            {
                "description": "Patients will be followed up for 2 years and cardiovascular events such as stroke, transient ischemic attack (TIA) will be recorded.", 
                "measure": "Incidence of cardiovascular events", 
                "safety_issue": "No", 
                "time_frame": "At 2 years"
            }
        ], 
        "source": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}